Ligand Pharmaceuticals Incorporated (LGND) — Strategic Asset Allocation Index
Ligand Pharmaceuticals Incorporated (LGND) has a Strategic Asset Allocation Index of 35.9% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $364.83 Million) total $364.83 Million, measured against net assets of $1.02 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check LGND cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Ligand Pharmaceuticals Incorporated Strategic Asset Allocation Index (2002–2025)
This chart shows how Ligand Pharmaceuticals Incorporated's Strategic Asset Allocation Index has evolved across 20 annual periods from 2002 to 2025. As of December 2025, the index stands at 35.9%, representing strategic assets of $364.83 Million against net assets of $1.02 Billion USD. See LGND free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Ligand Pharmaceuticals Incorporated (2002–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Ligand Pharmaceuticals Incorporated from 2002 to 2025, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Ligand Pharmaceuticals Incorporated (LGND) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 35.9% | $364.83 Million | $- | $364.83 Million | $1.02 Billion | ▲ +12.3 pp |
| 2024 | 23.6% | $195.93 Million | $- | $195.93 Million | $830.44 Million | ▲ +16.7 pp |
| 2023 | 6.9% | $48.32 Million | $- | $48.32 Million | $700.91 Million | ▲ +1.8 pp |
| 2022 | 5.1% | $30.49 Million | $27.49 Million | $3.00 Million | $597.49 Million | ▲ +1.1 pp |
| 2021 | 4.0% | $32.75 Million | $32.75 Million | $- | $821.16 Million | ▲ +2.0 pp |
| 2020 | 2.0% | $14.43 Million | $14.43 Million | $- | $709.52 Million | ▲ +1.1 pp |
| 2019 | 0.9% | $7.18 Million | $7.18 Million | $- | $767.23 Million | ▼ 0.0 pp |
| 2018 | 1.0% | $5.37 Million | $5.37 Million | $0.00 | $560.91 Million | ▼ -1.6 pp |
| 2017 | 2.5% | $10.65 Million | $4.21 Million | $6.44 Million | $418.65 Million | ▼ -0.2 pp |
| 2016 | 2.7% | $10.16 Million | $1.82 Million | $8.35 Million | $370.85 Million | ▼ -7.1 pp |
| 2015 | 9.9% | $30.10 Million | $372.00K | $29.73 Million | $304.39 Million | ▼ -24.1 pp |
| 2014 | 33.9% | $8.28 Million | $867.00K | $7.42 Million | $24.41 Million | ▲ +32.2 pp |
| 2013 | 1.7% | $867.00K | $867.00K | $- | $49.61 Million | ▼ -32.2 pp |
| 2012 | 34.0% | $8.99 Million | $788.00K | $8.21 Million | $26.48 Million | ▲ +28.7 pp |
| 2011 | 5.3% | $455.00K | $455.00K | $- | $8.65 Million | ▼ -222.4 pp |
| 2009 | 227.6% | $8.52 Million | $8.52 Million | $- | $3.74 Million | ▲ +217.8 pp |
| 2007 | 9.8% | $2.87 Million | $2.87 Million | $- | $29.11 Million | ▼ -10.5 pp |
| 2006 | 20.3% | $5.55 Million | $5.55 Million | $- | $27.35 Million | ▼ -12.9 pp |
| 2003 | 33.2% | $23.50 Million | $23.50 Million | $- | $70.73 Million | ▲ +20.2 pp |
| 2002 | 13.1% | $9.67 Million | $9.67 Million | $- | $74.02 Million | — |